A phase 2 trial of R1507, a monoclonal antibody to the insulin‐like growth factor‐1 receptor (IGF‐1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|16|2448-2456

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.16, 2014-08, pp. : 2448-2456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin‐like growth factor‐1 receptor (IGF‐1R) inhibition promotes expansion of human NK cells which maintain their potent antitumor activity against Ewing sarcoma cells

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 11, 2015-11 ,pp. : 1979-1985

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin‐like growth factor‐1 receptor (IGF‐1R) inhibition promotes expansion of human NK cells which maintain their potent antitumor activity against Ewing sarcoma cells

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 1979-1985

John Wiley & Sons Inc

Access to resources Recommend Favorite

IDENTIFICATION OF INSULIN-LIKE GROWTH FACTOR (IGF)-1 RECEPTOR IN HUMAN SPERM CELL

By Naz R. K.   Padman P.  

Archives of Andrology, Vol. 43, Iss. 2, 1999-09 ,pp. : 153-159

Informa Healthcare

Access to resources Recommend Favorite

let-7a and its target, insulin-like growth factor 1 receptor, are differentially expressed in recurrent prostate cancer

By          

International Journal of Molecular Medicine, Vol. 36, Iss. 5, 2015-01 ,pp. : 1409-1416

Spandidos Publications

Access to resources Recommend Favorite

Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden

By Clauson P G   Brismar K   Hall K   Linnarsson R   Grill V  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 58, Iss. 4, 1998-09 ,pp. : 353-360

Informa Healthcare

Access to resources Recommend Favorite